GSK Vaccine 134612
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK Vaccine 134612, covering 2012-07-20 to 2012-07-20. Get the full timeline:
Most recent: Clinical Trial Update: Immuno,Safety of GSK Vaccine 134612 Given at Age of 12-15 Months 15-18 Months Post-priming With GSK Vaccine 792014 [Phase 3]